Gyre Therapeutics, Inc.GYRENASDAQ
Loading
Income Before Tax Over TimeContracting
Percentile Rank93
3Y CAGR+15.3%
Studio
Year-over-Year Change

Pre-tax earnings

3Y CAGR
+15.3%/yr
Annual compound
Percentile
P93
Near historical high
vs 3Y Ago
1.5x
Solid growth
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$14.44M-37.8%
2024$23.22M+130.2%
2023$-76.97M-917.7%
2022$9.41M+110.7%
2021$-87.93M-56.4%
2020$-56.24M-1.9%
2019$-55.18M-83.6%
2018$-30.05M-39.4%
2017$-21.56M-27.2%
2016$-16.95M-